{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T05:28:06Z","timestamp":1676438886965},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3321,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.1995.tb00717.x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T15:39:29Z","timestamp":1279726769000},"page":"725-729","source":"Crossref","is-referenced-by-count":4,"title":["Defective in vivo expression and apparently normal in vitro expression of a newly identified 105-kDa lower lamina lucida protein in dystrophic epidermolysis bullosa"],"prefix":"10.1093","volume":"132","author":[{"given":"L. S.","family":"CHAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-D.","family":"FINE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"HAMMERBERG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"BAUER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. D.","family":"COOPER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,7,29]]},"reference":[{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0190-9622(91)70021-S","article-title":"Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa: a consensus report by the subcommittee on diagnosis and classification of the National Epidermolysis Bullosa Registry","volume":"24","author":"Fine","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/1523-1747.ep12525447","article-title":"Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in mechanobullous diseases","volume":"76","author":"Hintner","year":"1981","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0092-8674(91)90051-Y","article-title":"Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses","volume":"66","author":"Coulombe","year":"1991","journal-title":"Cell"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.1720261","article-title":"Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities","volume":"254","author":"Bonifas","year":"1991","journal-title":"Science"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archderm.1989.01670160068010","article-title":"19-DEJ-1, a hemidesmosomeanchoring filament complex-associated monoclonal antibody: definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa","volume":"125","author":"Fine","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archderm.1990.01670330067008","article-title":"19-DEJ-l, a monoclonal antibody to the hemidesmosome-anchoring filament complex, is the only reliable immunohistochemical pmbe for all major forms of junctional epidermolysis bullosa","volume":"126","author":"Fine","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0140-6736(86)90972-4","article-title":"GB3 monoclonal antibody for diagnosis of junctional epidermolysis bullosa","volume":"1","author":"Heagerty","year":"1986","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2133.1986.tb05707.x","article-title":"Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH7:2 monoclonal antibody: use in diagnosis","volume":"115","author":"Heagerty","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/1523-1747.ep12560795","article-title":"Type VII collagen is a normal component of epidermal basement membrane, which shows altered expression in recessive dystrophic epidermolysis bullosa","volume":"90","author":"Leigh","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/1523-1747.ep12712167","article-title":"The carboxyl-terminal domain of type VII collagen is present at the basement membrane in recessive dystrophic epidermolysis bullosa","volume":"92","author":"Rusenko","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1073\/pnas.88.16.6931","article-title":"Human type VII collagen: cDNA cloning and chromosomal mapping of the gene","volume":"88","author":"Parente","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1172\/JCI115680","article-title":"Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils","volume":"89","author":"Ryyn\u00e4nen","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB13|cit13","first-page":"797","article-title":"Human type VII collagen: genetic linkage of the gene (COL7A1) on chromosome 3 to dominant dystrophic epidermolysis bullosa","volume":"49","author":"Ryyn\u00e4nen","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1083\/jcb.103.4.1577","article-title":"Type VII collagen is a major structural component of anchoring fibrils","volume":"103","author":"Sakai","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/1523-1747.ep12259063","article-title":"KF-1 monoclonal antibody defines a specific basement membrane antigen defect in dystrophic forms of epidermolysis bullosa","volume":"82","author":"Fine","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/1523-1747.ep12522669","article-title":"Monoclonal antibodies to anchoring fibrils for the diagnosis of epidermolysis bullosa","volume":"81","author":"Goldsmith","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/1523-1747.ep12712151","article-title":"Chondroitin 6-sulfate proteoglycan but not heparan sulfate proteoglycan is abnormally expressed in skin basement membrane from patients with dominant and recessive dystrophic epidermolysis bullosa","volume":"92","author":"Fine","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/1523-1747.ep12365189","article-title":"Identification and partial characterization of a novel 105-kilodalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease","volume":"101","author":"Chan","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archderm.1994.01690030075012","article-title":"A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component","volume":"130","author":"Chan","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/1523-1747.ep12391690","article-title":"A novel 105-kDa basement membrane autoantigen: association with bullous pemphigold","volume":"103","author":"Cotell","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB21|cit21","article-title":"The newly identified 105-kD lower lamina lucida autoantigen is an acidic protein distinct from the 105-kD \u03b32 chains of laminin-5","author":"Chan","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/1523-1747.ep12616653","article-title":"Human dermal fibroblast interleukin-1 receptor antagonist (IL-1 ra) and interleukin-1 \u03b2 (IL-1 \u03b2) mRNA and protein are co-stimulated by phorbol ester: implication for a homeostatic mechanism","volume":"99","author":"Chan","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb00717.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1172\/JCI116033","article-title":"Epiligrin. the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease","volume":"90","author":"Domloge-Hultsch","year":"1992","journal-title":"J Clin Invest"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.1995.tb00717.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.1995.tb00717.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:58:13Z","timestamp":1676383093000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/132\/5\/725\/6681510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,29]]},"references-count":23,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.1995.tb00717.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,29]]}}}